Intimation under Regulation 30 of SEBI Listing Regulations
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has started commercial production of additional capacity at its Unit 3 facility in Gaddapotharam Village, Sangareddy District, Telangana, under an ongoing expansion plan first announced on November 10, 2023. Unit 3 is one of the company's manufacturing locations for pharmaceutical APIs (active pharmaceutical ingredients). The expansion is now operational and contributing to the company's production volumes. No specific capacity tonnage, capex figure, or revenue impact has been disclosed in this intimation.
Positive for shareholders as additional commissioned capacity can drive higher revenue and margins once utilization ramps up, though near-term impact may be muted until full utilization. Watch for capacity utilization updates and revenue contribution in upcoming quarterly results.